Literature DB >> 1577464

Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. I. Involvement of interleukin-6.

F Rosselli1, J Sanceau, J Wietzerbin, E Moustacchi.   

Abstract

The correction of chromosomal hypersensitivity to mitomycin C (MMC) in Fanconi anemia (FA) human lymphoblasts is observed by growth in a medium conditioned by normal human cells. Under the same conditions, the cytotoxic effect of MMC on FA cells is restored to an almost normal level. The addition of interleukin-6 (IL-6) to an unconditioned culture medium increased the resistance of FA cells to MMC cytotoxicity. This correcting effect is partially abolished by addition of an anti-IL-6 antibody to the conditioned medium. Both lymphoblasts and fibroblasts derived from FA patients demonstrate a reduction in IL-6 production. Moreover, this lymphokine is not induced by tumor necrosis factors alpha and beta (TNF alpha and TNF beta) in FA cells, as is the case in normal cells. It is suggested that the observed deficiency in IL-6 production may account for one of the major characteristics of FA disease, i.e., the defect in differentiation of the hematopoietic system.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1577464     DOI: 10.1007/bf00207040

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  27 in total

1.  Hypomutability in Fanconi anemia cells is associated with increased deletion frequency at the HPRT locus.

Authors:  D Papadopoulo; C Guillouf; H Mohrenweiser; E Moustacchi
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  Partial complementation of the Fanconi anemia defect upon transfection by heterologous DNA. Phenotypic dissociation of chromosomal and cellular hypersensitivity to DNA cross-linking agents.

Authors:  C Diatloff-Zito; F Rosselli; J Heddle; E Moustacchi
Journal:  Hum Genet       Date:  1990-12       Impact factor: 4.132

3.  Abnormal response to DNA crosslinking agents of Fanconi anemia fibroblasts can be corrected by transfection with normal human DNA.

Authors:  C Diatloff-Zito; D Papadopoulo; D Averbeck; E Moustacchi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

4.  Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens.

Authors:  A D Auerbach; S R Wolman
Journal:  Nature       Date:  1976-06-10       Impact factor: 49.962

5.  Regulation of the acute phase and immune responses: interleukin-6.

Authors: 
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

6.  Cocultivation of Fanconi anemia cells and of mouse lymphoma mutants leads to interspecies complementation of chromosomal hypersensitivity to DNA cross-linking agents.

Authors:  F Rosselli; E Moustacchi
Journal:  Hum Genet       Date:  1990-05       Impact factor: 4.132

7.  A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents.

Authors:  M S Sasaki; A Tonomura
Journal:  Cancer Res       Date:  1973-08       Impact factor: 12.701

8.  Antioxidant status of Fanconi anemia fibroblasts.

Authors:  J J Gille; H M Wortelboer; H Joenje
Journal:  Hum Genet       Date:  1987-09       Impact factor: 4.132

9.  The fate of 8-methoxypsoralen-photoinduced DNA interstrand crosslinks in Fanconi's anemia cells of defined genetic complementation groups.

Authors:  D Papadopoulo; D Averbeck; E Moustacchi
Journal:  Mutat Res       Date:  1987-11       Impact factor: 2.433

10.  Survival and mutagenic responses of mitomycin C-sensitive mouse lymphoma cell mutants to other DNA cross-linking agents.

Authors:  H Hama-Inaba; K Sato; E Moustacchi
Journal:  Mutat Res       Date:  1988-09       Impact factor: 2.433

View more
  13 in total

Review 1.  Fanconi anaemia.

Authors:  M D Tischkowitz; S V Hodgson
Journal:  J Med Genet       Date:  2003-01       Impact factor: 6.318

Review 2.  Recent insights into the molecular basis of Fanconi anemia: genes, modifiers, and drivers.

Authors:  Ronald S Cheung; Toshiyasu Taniguchi
Journal:  Int J Hematol       Date:  2017-06-19       Impact factor: 2.490

3.  Fanconi anemia proteins and endogenous stresses.

Authors:  Qishen Pang; Paul R Andreassen
Journal:  Mutat Res       Date:  2009-07-31       Impact factor: 2.433

4.  Evidence that DNA damage triggers interleukin 10 cytokine production in UV-irradiated murine keratinocytes.

Authors:  C Nishigori; D B Yarosh; S E Ullrich; A A Vink; C D Bucana; L Roza; M L Kripke
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

5.  Irreversible repression of DNA synthesis in Fanconi anemia cells is alleviated by the product of a novel cyclin-related gene.

Authors:  M Digweed; U Günthert; R Schneider; H Seyschab; R Friedl; K Sperling
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

6.  Impaired interferon production and natural killer cell activation in patients with the skin cancer-prone disorder, xeroderma pigmentosum.

Authors:  A A Gaspari; T A Fleisher; K H Kraemer
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

Review 7.  Oxidative stress in Fanconi anemia hematopoiesis and disease progression.

Authors:  Wei Du; Zsuzsanna Adam; Reena Rani; Xiaoling Zhang; Qishen Pang
Journal:  Antioxid Redox Signal       Date:  2008-11       Impact factor: 8.401

Review 8.  TNF-α signaling in Fanconi anemia.

Authors:  Wei Du; Ozlem Erden; Qishen Pang
Journal:  Blood Cells Mol Dis       Date:  2013-07-24       Impact factor: 3.039

9.  Repression of Fanconi anemia gene (FACC) expression inhibits growth of hematopoietic progenitor cells.

Authors:  G M Segal; R E Magenis; M Brown; W Keeble; T D Smith; M C Heinrich; G C Bagby
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

10.  Fanconi anemia proteins and their interacting partners: a molecular puzzle.

Authors:  Tagrid Kaddar; Madeleine Carreau
Journal:  Anemia       Date:  2012-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.